Piramal Pharma Ltd. (PPLPHARMA)
Market Closed
5 Aug, 10:00
XNSE XNSE Primary MSE ₹
206. 78
+4.28
+2.1136%
₹
190.08B Market Cap
- P/E Ratio
- Div Yield
9.35M Volume
0 Eps
₹ 202.5
Previous Close Want to track PPLPHARMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Piramal Pharma Ltd. (PPLPHARMA) Statistics
Valuation metrics
Market Cap 190.08B
Enterprise value 304.05B
Trailing P/E (ttm) -82.54
Forward P/E -
PEG ratio 0.83
Price/Sales (ttm) 2.82
Price/Book (mrq) 3.17
Enterprise Value/Revenue 3.3
Enterprise Value/EBITDA 31.28
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 10.17M
Average volume (90 days) 7.5M
Price summary
52-Week low 132.3
52-Week high 209.44
Beta -
50-Day moving average 174.7
200-Day moving average 162.94
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.14
Trailing annual dividend yield 0.0007%
5-Year annual dividend yield -
Payout ratio -0.06
Dividend Date 29 Aug 2025
Ex-Dividend Date 16 Jul 2025
Last split factor 1,023:1,000
Last split Date 2 Aug 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.03%
Operating margin 0.02%
Operational effectiveness
Return on assets -0.02%
Return on equity -0.04%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 69.59
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.37
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 10.25
Total debt (mrq) -
Total Debt/Equity (mrq) 0.7
Current ratio (mrq) 1.51%
Book value per share (mrq) 61.7
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
